Forge Biologics

We’ve been feeling inspired by the Olympic athletes here at Forge! Just as they strive for gold, our team is pushing the limits for excellence in manufacturing. From our team to yours, go USA!

We were honored to host leaders from Ohio Life Sciences, JobsOhio, One Columbus, and global economic development groups for a hands-on tour of our 200,000 sq. ft. facility showcasing why we are proud to call Columbus home. With its expanding gene therapy industry, access to top-level talent, and much more, Columbus is forging the future of biotech!

Navigating where to start with a new AAV program can be challenging. In our latest Endpoints News article, we’ve highlighted two high-powered starting points that poise a program for success. Read the full article by our Director of Technical Sales, Brianna Barrett, Ph.D., including case studies here ➡️ https://bit.ly/4cfI8Jy

Gene therapy developers want a manufacturing partner aligned with their mission. That's why we are focused on 👇 • Advancing molecular development • Making process improvements • Enhancing analytics • Scaling out • Scaling up Learn how Forge partners with developers to enable access to gene therapies through better manufacturing ➡️ https://bit.ly/3Yz2LgB

Crossing the finish line never felt so good! Our 10 Team Forge riders powered through over 500 miles this weekend to support cancer research with Pelotonia.   We celebrate the extraordinary dedication of our riders and their fundraising efforts in support of Pelotonia and their #OneGoal of ending cancer. Together, we can forge a path towards a cancer-free world.   #Pelotonia #OneGoal #ForgeWithUs

Today, our 2024 Ignite Internship program wraps up and we held our Ignite Interns Awards. Interns who best exemplified Forge's core values of HOPE—Hardworking, Open, Purpose-driven and Engaged—as well as overall impact during their internship received awards. We also held a workshop on resume building and utilizing social media like LinkedIn for career development. We are so proud of their accomplishments and the impact that they have made during their time here. As they return to their schools, we want to thank this class for their hard work, dedication, and openness to growing with Forge!

Our platform HEK293 suspension Ignition™ cell line is used by >95% of our clients. Here’s why 👇 • Applicable across a wide variety of indications, serotypes, and stages of development • Well-documented history with regulatory feedback • Fully qualified Master Cell Bank and Working Cell Bank produced at Forge • >90% full capsid post-enrichment with CsCl, with undetectable empty particles Learn how you can accelerate your AAV program at Forge ➡️https://bit.ly/3Sys12C

🧬 Starting with the end in mind. We developed Blaze, our research-grade production to help gene therapy developers access quick, scalable manufacturing at 1-40L. Starting development with a commercially viable platform, like Blaze, can support easier development, scale-up, reduce bridging studies, and minimize risks to future approvals. Learn more about our Blaze offering ➡️ https://hubs.li/Q02HFmkz0

We’re back from Yokohama! Forge’s Linas Padegimas, Ph.D., and Clifal Aquino recently presented at the 30th Annual Meeting of the Japan Society for Gene and Cell Therapy in Yokohama, Japan. They delivered insights on our AAV platform process development and scale-up manufacturing, as well as molecular improvements for increased AAV yield and safety. Thank you to all the gene therapy developers in the APAC region for the engaging discussions.

Colleagues gathered for some food and fun during Forge's annual Friends & Family gathering! KONA Ice food trucks provided a cool treat on a hot summer day, and games, a silent auction, and a Versity blood drive were at hand to round out a wonderful afternoon with friends and family.